The use of cellular immunoadsorbents to prepare polyclonal antibodies that distinguish between antigens derived from human melanoma cells and autologous lymphocytes-Reference-Cited by-同舟云学术

The use of cellular immunoadsorbents to prepare polyclonal antibodies that distinguish between antigens derived from human melanoma cells and autologous lymphocytes

Published:1983-03 Issue:3 Volume:14 Page:191-195
ISSN:0340-7004
Container-title:Cancer Immunology Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Kelleher PeterJ.,Mathews HerbertL.,Moore GeorgeE.,Minden Percy

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/BF00205359.pdf

Reference24 articles.

1. Avrameas S, Ternynck T (1969) The crosslinking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents. Immunochemistry 6:53

2. Brown JP, Wright PW, Hart CE, Woodbury RG, Hellstr�m KE, Hellstr�m I (1980) Protein antigens of normal and malignant human cells identified by immunoprecipitation with monoclonal antibodies. J Biol Chem 225:4980

3. Bruggen J, Sorg C, Macher E (1978) Membrane-associated antigens of human malignant melanoma. V. Serological typing of cell lines using antisera from nonhuman primates. Cancer Immunol Immunother 5:53

4. Carrel S, Accolla RS, Carmagnola AL, Mach JP (1980) Common human melanoma-associated antigen(s) detected by monoclonal antibodies. Cancer Res 40:2523

5. Colcher D, Hand PH, Nati M, Schlom J (1981) A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci USA 78:3199

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Anchoring of Antineoplastic Ferrocene and Phthalocyanine Derivatives on Water-Soluble Polymeric Drug Carriers Derived from Lysine and Aspartic Acid;Metal-Based Drugs;2008-12-06

2. A solid-phase radioimmunoassay to detect antibodies produced by hybridomas to antigens derived from human melanoma cells;Cancer Immunology Immunotherapy;1983-03